Cefepime-Taniborbactam in Complicated Urinary Tract Infection.

The article focuses on comparing the efficacy of cefepime-taniborbactam with meropenem for treating complicated urinary tract infections, indicating superior clinical success with cefepime-taniborbactam. Concerns are raised regarding unbalanced dosing between the drugs, the exclusion of certain bacterial strains, and the choice of comparator, which may affect the trial's interpretation and applicability to current treatment guidelines.